References
- Al-Abdely HM, Najvar LK, Bocanegra R, Graybill JR. (2005). Antifungal therapy of experimental cerebral phaeohyphomycosis due to Cladophialophora bantiana. Antimicrob Agents Chemother, 49, 1701–1707.
- Bartus RT, Elliott PJ, Dean RL, Hayward NJ, Nagle TL, Huff MR, Snodgrass PA, Blunt DG. (1996). Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7. Exp Neurol, 142, 14–28.
- Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. (2007). Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev, 59, 454–477.
- Bradbury MW. (1985). The blood-brain barrier. Transport across the cerebral endothelium. Circ Res, 57, 213–222.
- Broadwell RD. (1989). Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal. Acta Neuropathol, 79, 117–128.
- Chen W, Gu B, Wang H, Pan J, Lu W, Hou H. (2008). Development and evaluation of novel itraconazole-loaded intravenous nanoparticles. Int J Pharm, 362, 133–140.
- de Boer AG, Gaillard PJ. (2007). Drug targeting to the brain. Annu Rev Pharmacol Toxicol, 47, 323–355.
- Gotti C, Clementi F. (2004). Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol, 74, 363–396.
- Kang YS, Saito Y, Pardridge WM. (1995). Pharmacokinetics of [3H] biotin bound to different avidin analogues. J Drug Target, 3, 159–165.
- Kreuter J. (2001). Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev, 47, 65–81.
- Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, Pathak K. (2008). Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm, 358, 285–291.
- Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL, Lee SK, Shankar P, Manjunath N. (2007). Transvascular delivery of small interfering RNA to the central nervous system. Nature, 448, 39–43.
- Lafon M. (2005). Rabies virus receptors. J Neurovirol, 11, 82–87.
- Lee MK, Lim SJ, Kim CK. (2007). Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials, 28, 2137–2146.
- Lentz TL. (1990). Rabies virus binding to an acetylcholine receptor alpha-subunit peptide. J Mol Recognit, 3, 82–88.
- Lentz TL, Burrage TG, Smith AL, Crick J, Tignor GH. (1982). Is the acetylcholine receptor a rabies virus receptor? Science, 215, 182–184.
- Liu Y, Huang R, Han L, Ke W, Shao K, Ye L, Lou J, Jiang C. (2009). Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials, 30, 4195–4202.
- Mishra V, Mahor S, Rawat A, Gupta PN, Dubey P, Khatri K, Vyas SP. (2006). Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J Drug Target, 14, 45–53.
- Nobs L, Buchegger F, Gurny R, Allémann E. (2006). Biodegradable nanoparticles for direct or two-step tumor immunotargeting. Bioconjug Chem, 17, 139–145.
- Schnyder A, Krähenbühl S, Drewe J, Huwyler J. (2005). Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects. J Drug Target, 13, 325–335.
- Tosi G, Costantino L, Rivasi F, Ruozi B, Leo E, Vergoni AV, Tacchi R, Bertolini A, Vandelli MA, Forni F. (2007). Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. J Control Release, 122, 1–9.
- Townsend SA, Evrony GD, Gu FX, Schulz MP, Brown RH Jr, Langer R. (2007). Tetanus toxin C fragment-conjugated nanoparticles for targeted drug delivery to neurons. Biomaterials, 28, 5176–5184.
- Turgut M, Ozsunar Y, Oncü S, Akyüz O, Ertugrul MB, Tekin C, Gültekin B, Sakarya S. (2008). Invasive fungal granuloma of the brain caused by Aspergillus fumigatus: a case report and review of the literature. Surg Neurol, 69, 169–74; discussion 174.
- Weiss B, Schneider M, Muys L, Taetz S, Neumann D, Schaefer UF, Lehr CM. (2007). Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-co-glycolide) nanoparticles for versatile surface modification. Bioconjug Chem, 18, 1087–1094.
- Wong JW, Nisar UR, Yuen KH. (2003). Liquid chromatographic method for the determination of plasma itraconazole and its hydroxyl metabolite in pharmacokinetic/bioavailability studies. J Chromatography B, 798, 335–360.
- Xia CF, Boado RJ, Pardridge WM. (2009). Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology. Mol Pharm, 6, 747–751.